Company Filing History:
Years Active: 2019
Title: Danja Großbach: Innovator in Pharmaceutical Chemistry
Introduction
Danja Großbach is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of complex compounds. Her work is recognized for its potential impact on drug development and therapeutic applications.
Latest Patents
Danja Großbach holds a patent for the "Synthesis of copanlisib and its dihydrochloride salt." This invention relates to a novel method of preparing copanlisib, copanlisib dihydrochloride, or hydrates of copanlisib dihydrochloride. The patent also covers novel intermediate compounds and their use in the preparation of these compounds. Additionally, it discusses copanlisib dihydrochloride hydrates as valuable compounds in pharmaceutical applications.
Career Highlights
Danja Großbach is currently employed at Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. Her role involves research and development, focusing on innovative methods for drug synthesis. With one patent to her name, she has established herself as a key player in her field.
Collaborations
Danja collaborates with talented colleagues, including Jan-Georg Peters and Philipp Rubenbauer. These partnerships enhance her research efforts and contribute to the advancement of pharmaceutical innovations.
Conclusion
Danja Großbach's work exemplifies the importance of innovation in the pharmaceutical industry. Her contributions to the synthesis of copanlisib highlight her role as a pioneering inventor. Through her research and collaborations, she continues to make strides in the field of pharmaceutical chemistry.